Silent heart injury after endoscopy? new study investigates
NCT ID NCT07179549
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will check if high-risk patients (those with serious health conditions) experience heart muscle damage after a routine upper and lower GI endoscopy. Researchers will measure a heart protein called troponin before and after the procedure in 120 patients. The goal is to find out how often this silent heart injury happens, which could improve safety for future procedures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this study finds that heart damage is common after GI endoscopy in high-risk patients, it could lead to better monitoring and care to prevent complications.
- What could go wrong
- This is a small, early observational study (120 patients) that only measures a marker of heart damage, not actual heart attacks or outcomes. It may not prove that the damage is clinically important.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients considered high risk
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Outpatients scheduled for upper and lower GI endoscopy * ASA class 3 or 4: patients considered by anesthesiologists at "high risk" of postoperative complications, based on their comorbidities Exclusion Criteria: * Symptomatic coronary artery disease at the time of inclusion * Pulmonary embolism less than two weeks before inclusion * Septic shock less than two weeks before inclusion * Patients with renal failure, with glomerular filtration rate\<40 ml/min * Patient not covered by social security * Patient is pregnant * Protected Patients
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gi endoscopy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.